Navigation Links
Yashoda Cancer Institute Treats First Patient in India Using RapidArc Radiotherapy Technology
Date:4/20/2009

HYDERABAD, India, April 20 /PRNewswire/ -- Clinicians in India have carried out the country's first treatment using a new, faster form of radiotherapy that extends more advanced care to more patients. A 72-year-old bladder cancer patient received the pioneering treatment using RapidArc radiotherapy technology from Varian Medical Systems (NYSE: VAR) at Yashoda Cancer Institute in Hyderabad.

Varian's RapidArc technology makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT. RapidArc delivers a precise and efficient treatment in single or multiple arcs of the treatment machine around the patient and offers several advantages over traditional approaches, according to clinician Dr. Srinivas Chilikuri.

"The whole treatment duration including set-up and check was completed in ten minutes, which involved just 90 seconds of 'beam-on' time," said Dr. Chilikuri. "We witnessed high dose conformity, excellent target coverage and good critical tissue sparing but the main advantage was the speed of the treatment."

Dr. Chilikuri said speed is particularly important because of the large number of cancer patients in India. "In a country like ours with a heavy cancer burden there is a real issue with waiting lists," he said. "We deal with this by prioritising and optimizing treatment facilities and RapidArc is an excellent example of this approach. With this, we can carry out faster and more precise treatments with less complex delivery and less complicated quality assurance requirements.

"The whole point of acquiring RapidArc was to treat more and more patients with high precision technology. With RapidArc's fast and efficient treatment delivery we will significantly increase the number of patients treated with advanced conformal techniques."

Dr. Chilikuri said the clinical team at Yashoda plans to use RapidArc for a variety of common cancers such as head & neck, cervical, prostate and lung, as well as complicated tumors which are otherwise difficult to treat with other techniques.

Yashoda Cancer Institute is an international quality 200 bed comprehensive cancer research and treatment center operated by Yashoda Hospitals. The cancer institute provides healthcare to 7,000 cancer patients every year. A comprehensive cancer center with state-of-the-art technology, the hospital treats patients from south and east India, South Asia and the Middle East. Dheeraj Gorukanti, chief executive officer of Yashoda Hospitals Group, said, "Yashoda Hospitals is proud to be one of the first sites in the world to implement Varian's RapidArc system. We believe it will provide a real edge in helping patients fight cancer."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... Bionic Sports Nutrition LLC, an American company ... it had a successful January ECRM Trade Show in Hilton Head, SC. , ... allows it to provide its products to all clients at reasonable prices. At the ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
(Date:1/20/2017)... New York, NY (PRWEB) , ... January 20, ... ... drinks – VW+ 001 and its sugar-free alternative VW+ 002. The drinks have ... the body with optimal conditions to perform during your workout. , After a ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following a ... Biscuit” is the creation of published author, Marlyn Ivey, born in Lynn Haven, Florida and ... to school and at 19 years of age, he joined the Navy and got married ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: a story of love, ... who lives in Lafayette, Indiana where she works in a daycare and looks for ... , Published by Christian Faith Publishing, Sara Seymour’s new book is an adventure of ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017  Palladian Health, a ... announced the launch of an opioid management program ... on opioids and helps stem the growing tide ... prescribed to treat chronic non-cancer pain (back pain, ... risks and lack of evidence regarding long-term effectiveness. ...
(Date:1/20/2017)... -- Avillion LLP, a co-developer and financier of late-stage ... MD MBA as Chief Medical Officer. Dr Weinberg will be based ... ... spent more than 17 years as a pharmaceutical and biotech executive ... Over the course of his career, he has interfaced with the ...
(Date:1/19/2017)... Report Details What can be ... going to grow at the fastest rates? This visiongain ... trends, opportunities and prospects. Our 190-page report provides ... areas in the industry and the future market prospects. ... the all the major categories of the ophthalmic devices ...
Breaking Medicine Technology: